Location: Home
  • search
  • go
  • Relate News
  • 4/14/2015Over 80% Listed Chinese Pharma Cos Saw Rising Revenues and Profits
  • 4/13/2015The Lancet Urges China to Prevent Plagiarism and Fraud in Scientific R...
  • 4/13/2015Ali Health Offers a Revolutionary Moment for China's Healthcare Indust...
  • 4/13/2015NHFPC Minister LI Bin: Drug Price Unreasonable, Negotiation to Begin T...
  • 4/13/2015Sichuan Provincial CDC Director Under Investigation
  • 4/13/2015NHFPC: Online Medical Diagnosis and Treatment Restricted to Licensed M...
  • 4/12/2015Aptar Pharma Granted Import License for Preservative Free Multi-dose S...
  • 4/10/2015Upcoming Event: Access & Commercial Strategy
  • 4/10/2015Upcoming Event: Pharma Business Development Course
  • 4/10/2015Drug Registration Reform Direction Revealed at the CFDA Conference
  • 4/10/2015Walvax Biotech, Tigermed Agree to Jointly Set Up Healthcare M&A Fu...
  • 4/9/2015Uni-Bio Science's Osteoporos NDA Accepted by CFDA
  • 4/9/2015Tonghua Dongbao Pharma to Build $60M API Plant
  • 4/9/2015More Chinese Pharma Cos Cuts Sales Force and Switch to Agency Sales
  • 4/9/2015MIIT Publishes 2014 Chinese Pharmaceutical Company Ranking
  • 4/8/2015Australian and Chinese Researchers Make Drug Research Breakthrough for...
  • 4/8/2015Recent Executive Movements
  • 4/8/2015GSK to Take Over China Vaccine Business from Novartis Following Global...
  • 4/8/2015Hospital Oncology Drug Consumption of Six Cities in Yangtze River Vici...
  • 4/8/2015Review of Drug Consumption in Chinese County Level Hospitals
  • 4/8/2015Financial-related Company News in Brief
  • 4/8/2015Resverlogix Receives Two Chinese Patents for Its BET Inhibitor
  • 4/7/2015Global Strategic Partners Merck and Pfizer Finalize Agreement to Co-Pr...
  • 4/7/2015Upcoming Event: Asia Healthcare Summit
  • 4/7/2015Upcoming Event: ISPE
  • 4/7/2015Upcoming Event: Biopharma Development & Production
  • 4/6/2015Medidata Expands Partnership with PKU for Clinical Cloud-Based Technol...
  • 4/6/2015MOHRSS Issues Adjustment Notice of the 2009 NDRL
  • 4/3/2015Wuxi PharmaTech's CMO Subsidiary STA Approved for IPO in China
  • 4/3/2015J&J CEO Pledges Long Term Commitment to China
  • Page:387/720 Total number of articles:21594: [First][<<] [385] [386] [387] [388] [389] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group